Search


      
Advanced Search

  • enter search term(s) as free text (like Google)
  • press 'magnification glass' to start search
  • search results will be displayed below (scroll down ↓)
  • select entries (mark checkboxes)
  • if you want to export data, click the checkbox for each entry and finally click on the symbol in the upper right corner to proceed
To improve SABIO-RK data interoperability, semantic markup was added to web pages as described and defined by Bioschemas.
This structured information makes it easier to discover, collate and analyse our data.

SABIO-RK entries

<< back to entry ranges

65001 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65002 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65003 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65004 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65005 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65006 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65007 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65008 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65009 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65010 Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis ...
65011 Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from ...
65012 Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from ...
65013 Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from ...
65014 Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from ...
65015 Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from ...
65016 Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from ...
65017 Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from ...
65018 Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from ...
65019 Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from ...
65020 The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase
65021 The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase
65022 The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase
65023 The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase
65024 Enzymatic activity and partial purification of solanapyrone synthase: first enzyme catalyzing Diels-Alder ...
65025 Purification and characterization of sepiapterin reductase from rat erythrocytes.
65026 Purification and characterization of sepiapterin reductase from rat erythrocytes.
65027 Purification and characterization of sepiapterin reductase from rat erythrocytes.
65028 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65029 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65030 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65031 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65032 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65033 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65034 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65035 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65036 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65037 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65038 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65039 Structure based discovery of clomifene as a potent inhibitor of cancer-associated mutant IDH1
65040 Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: ...
65041 Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: ...
65042 Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: ...
65043 Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: ...
65044 Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: ...
65045 Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: ...
65046 Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: ...
65047 Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: ...
65048 Distinct biochemical properties of human serine hydroxymethyltransferase compared with the Plasmodium enzyme: ...
65049 Optimized determination of gamma-glutamyltransferase by reaction-rate analysis.
65050 Optimized determination of gamma-glutamyltransferase by reaction-rate analysis.
65051 Isolation of gamma-glutamyltransferase from human liver, and comparison with the enzyme from human kidney.
65052 Isolation of gamma-glutamyltransferase from human liver, and comparison with the enzyme from human kidney.
65053 Isolation of gamma-glutamyltransferase from human liver, and comparison with the enzyme from human kidney.
65054 Isolation of gamma-glutamyltransferase from human liver, and comparison with the enzyme from human kidney.
65055 Isolation of gamma-glutamyltransferase from human liver, and comparison with the enzyme from human kidney.
65056 Isolation of gamma-glutamyltransferase from human liver, and comparison with the enzyme from human kidney.
65057 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65058 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65059 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65060 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65061 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65062 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65063 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65064 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65065 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65066 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65067 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65068 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65069 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65070 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65071 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65072 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65073 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65074 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65075 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65076 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65077 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65078 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65079 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65080 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65081 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65082 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65083 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65084 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65085 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65086 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65087 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65088 Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds
65089 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65090 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65091 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65092 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65093 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65094 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65095 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65096 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65097 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65098 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65099 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65100 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65101 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65102 Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer
65103 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65104 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65105 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65106 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65107 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65108 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65109 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65110 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65111 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65112 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65113 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65114 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65115 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65116 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65117 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65118 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65119 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65120 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65121 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65122 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65123 Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by ...
65124 Extremely stable indole-3-glycerol-phosphate synthase from hyperthermophilic archaeon Pyrococcus furiosus
65125 Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate ...
65126 Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate ...
65127 Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate ...
65128 Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate ...
65129 Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate ...
65130 Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate ...
65131 Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate ...
65132 Metabolic interactions of rosmarinic acid with human cytochrome P450 monooxygenases and uridine diphosphate ...
65133 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65134 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65135 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65136 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65137 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65138 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65139 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65140 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65141 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65142 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65143 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65144 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65145 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65146 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65147 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65148 Single Amino Acid Change in 6-Phosphogluconate Dehydrogenase from Synechocystis Conveys Higher Affinity for ...
65149 Characterization of biochemical properties of an apurinic/apyrimidinic endonuclease from Helicobacter pylori.
65150 Characterization of biochemical properties of an apurinic/apyrimidinic endonuclease from Helicobacter pylori.
65151 Characterization of biochemical properties of an apurinic/apyrimidinic endonuclease from Helicobacter pylori.
65152 Characterization of biochemical properties of an apurinic/apyrimidinic endonuclease from Helicobacter pylori.
65153 Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter
65154 Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter
65155 Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter
65156 Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter
65157 Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter
65158 Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter
65159 Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate
65160 Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate
65161 Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate
65162 Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate
65163 Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate
65164 Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate
65165 Molecular characterization of cytosolic cysteine synthase in Mimosa pudica
65166 Molecular characterization of cytosolic cysteine synthase in Mimosa pudica
65167 Purification and characterization of novel bi-functional GH3 family β-xylosidase/β-glucosidase from ...
65168 Purification and characterization of a hydroxynitrile lyase from Amygdalus pedunculata Pall
65169 B-factor-saturation mutagenesis as a strategy to increase the thermostability of α-L-rhamnosidase from ...
65170 B-factor-saturation mutagenesis as a strategy to increase the thermostability of α-L-rhamnosidase from ...
65171 B-factor-saturation mutagenesis as a strategy to increase the thermostability of α-L-rhamnosidase from ...
65172 B-factor-saturation mutagenesis as a strategy to increase the thermostability of α-L-rhamnosidase from ...
65173 B-factor-saturation mutagenesis as a strategy to increase the thermostability of α-L-rhamnosidase from ...
65174 B-factor-saturation mutagenesis as a strategy to increase the thermostability of α-L-rhamnosidase from ...
65175 Receptor protein of Lysinibacillus sphaericus mosquito-larvicidal toxin displays amylomaltase activity
65176 Receptor protein of Lysinibacillus sphaericus mosquito-larvicidal toxin displays amylomaltase activity
65177 Receptor protein of Lysinibacillus sphaericus mosquito-larvicidal toxin displays amylomaltase activity
65178 The yeast inositol monophosphatase is a lithium- and sodium-sensitive enzyme encoded by a non-essential gene ...
65179 The yeast inositol monophosphatase is a lithium- and sodium-sensitive enzyme encoded by a non-essential gene ...
65180 The yeast inositol monophosphatase is a lithium- and sodium-sensitive enzyme encoded by a non-essential gene ...
65181 The yeast inositol monophosphatase is a lithium- and sodium-sensitive enzyme encoded by a non-essential gene ...
65182 The yeast inositol monophosphatase is a lithium- and sodium-sensitive enzyme encoded by a non-essential gene ...
65183 The yeast inositol monophosphatase is a lithium- and sodium-sensitive enzyme encoded by a non-essential gene ...
65184 Identification and characterization of a sac domain-containing phosphoinositide 5-phosphatase
65185 Purification, molecular cloning, and sequence analysis of sucrose-6F-phosphate phosphohydrolase from plants
65186 Purification, molecular cloning, and sequence analysis of sucrose-6F-phosphate phosphohydrolase from plants
65187 Purification, molecular cloning, and sequence analysis of sucrose-6F-phosphate phosphohydrolase from plants
65188 Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition ...
65189 Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition ...
65190 Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition ...
65191 Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition ...
65192 Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition ...
65193 Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition ...
65194 Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition ...
65195 Characterization of kinetics of human cytochrome P450s involved in bioactivation of flucloxacillin: inhibition ...
65196 Kinetics of manganese lipoxygenase with a catalytic mononuclear redox center
65197 Kinetics of manganese lipoxygenase with a catalytic mononuclear redox center
65198 Kinetics of manganese lipoxygenase with a catalytic mononuclear redox center
65199 Kinetics of manganese lipoxygenase with a catalytic mononuclear redox center
65200 Kinetics of manganese lipoxygenase with a catalytic mononuclear redox center
65201 Purification and characterization of linoleate 8-dioxygenase from the fungus Gaeumannomyces graminis as a ...
65202 Purification and characterization of linoleate 8-dioxygenase from the fungus Gaeumannomyces graminis as a ...
65203 Purification and characterization of linoleate 8-dioxygenase from the fungus Gaeumannomyces graminis as a ...
65204 Purification and characterization of linoleate 8-dioxygenase from the fungus Gaeumannomyces graminis as a ...
65205 Identification and reconstitution of the yeast mitochondrial transporter for thiamine pyrophosphate
65206 Identification and reconstitution of the yeast mitochondrial transporter for thiamine pyrophosphate
65207 Identification and reconstitution of the yeast mitochondrial transporter for thiamine pyrophosphate
65208 Identification and reconstitution of the yeast mitochondrial transporter for thiamine pyrophosphate
65209 Identification and reconstitution of the yeast mitochondrial transporter for thiamine pyrophosphate
65210 Identification and reconstitution of the yeast mitochondrial transporter for thiamine pyrophosphate
65211 High-activity production of xylanase by Pichia stipitis: Purification, characterization, kinetic evaluation ...
65212 A rapid and sensitive colorimetric assay for the determination of adenosine kinase activity
65213 Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and ...
65214 Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and ...
65215 Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and ...
65216 Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and ...
65217 Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and ...
65218 Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and ...
65219 Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and ...
65220 Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from ...
65221 Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from ...
65222 Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from ...
65223 Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from ...
65224 Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from ...
65225 Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from ...
65226 Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from ...
65227 Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from ...
65228 Structural and mutational analysis of substrate complexation by anthranilate phosphoribosyltransferase from ...
65229 Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma
65230 Evaluation of the activity of β-glucosidase immobilized on polydimethylsiloxane (PDMS) with a microfluidic ...
65231 Evaluation of the activity of β-glucosidase immobilized on polydimethylsiloxane (PDMS) with a microfluidic ...
65232 Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ...
65233 Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ...
65234 Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ...
65235 Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ...
65236 Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ...
65237 Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ...
65238 Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ...
65239 Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ...
65240 Structural and Functional Analysis of UGT92G6 Suggests an Evolutionary Link Between Mono- and Disaccharide ...
65241 Structural and Functional Analysis of UGT92G6 Suggests an Evolutionary Link Between Mono- and Disaccharide ...
65242 Structural and Functional Analysis of UGT92G6 Suggests an Evolutionary Link Between Mono- and Disaccharide ...
65243 The effect of alpha-solanine on the activity, gene expression, and kinetics of arylamine N-acetyltransferase ...
65244 The effect of alpha-solanine on the activity, gene expression, and kinetics of arylamine N-acetyltransferase ...
65245 The effect of alpha-solanine on the activity, gene expression, and kinetics of arylamine N-acetyltransferase ...
65246 The effect of alpha-solanine on the activity, gene expression, and kinetics of arylamine N-acetyltransferase ...
65247 Zinc ion acts as a cofactor for serine/threonine kinase MST3 and has a distinct role in autophosphorylation of ...
65248 Zinc ion acts as a cofactor for serine/threonine kinase MST3 and has a distinct role in autophosphorylation of ...
65249 Zinc ion acts as a cofactor for serine/threonine kinase MST3 and has a distinct role in autophosphorylation of ...
65250 Zinc ion acts as a cofactor for serine/threonine kinase MST3 and has a distinct role in autophosphorylation of ...
65251 Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
65252 Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
65253 Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
65254 Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
65255 Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
65256 Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
65257 Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
65258 Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
65259 Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
65260 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65261 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65262 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65263 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65264 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65265 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65266 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65267 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65268 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65269 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65270 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65271 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65272 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65273 Molecular and biochemical characterization of two brassinosteroid sulfotransferases from Arabidopsis, AtST4a ...
65274 Cutting Edge: IL-1 receptor-associated kinase 4 structures reveal novel features and multiple conformations
65275 Cutting Edge: IL-1 receptor-associated kinase 4 structures reveal novel features and multiple conformations
65276 Cutting Edge: IL-1 receptor-associated kinase 4 structures reveal novel features and multiple conformations
65277 PRKX, a phylogenetically and functionally distinct cAMP-dependent protein kinase, activates renal epithelial ...
65278 PRKX, a phylogenetically and functionally distinct cAMP-dependent protein kinase, activates renal epithelial ...
65279 Biochemical characterization of the kinase domain of the rice disease resistance receptor-like kinase XA21
65280 A protein kinase family in Arabidopsis phosphorylates chloroplast precursor proteins
65281 A protein kinase family in Arabidopsis phosphorylates chloroplast precursor proteins
65282 A protein kinase family in Arabidopsis phosphorylates chloroplast precursor proteins
65283 Calcium/calmodulin up-regulates a cytoplasmic receptor-like kinase in plants
65284 Calcium/calmodulin up-regulates a cytoplasmic receptor-like kinase in plants
65285 Calcium/calmodulin up-regulates a cytoplasmic receptor-like kinase in plants
65286 Novel substrates of Mycobacterium tuberculosis PknH Ser/Thr kinase
65287 Novel substrates of Mycobacterium tuberculosis PknH Ser/Thr kinase
65288 Novel substrates of Mycobacterium tuberculosis PknH Ser/Thr kinase
65289 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65290 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65291 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65292 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65293 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65294 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65295 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65296 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65297 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65298 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65299 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65300 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65301 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65302 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65303 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65304 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65305 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65306 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65307 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65308 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65309 TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, ...
65310 Phosphorylation of calcineurin B-like (CBL) calcium sensor proteins by their CBL-interacting protein kinases ...
65311 Phosphorylation of calcineurin B-like (CBL) calcium sensor proteins by their CBL-interacting protein kinases ...
65312 Phosphorylation of calcineurin B-like (CBL) calcium sensor proteins by their CBL-interacting protein kinases ...
65313 Phosphorylation of calcineurin B-like (CBL) calcium sensor proteins by their CBL-interacting protein kinases ...
65314 Phosphorylation of calcineurin B-like (CBL) calcium sensor proteins by their CBL-interacting protein kinases ...
65315 Phosphorylation of calcineurin B-like (CBL) calcium sensor proteins by their CBL-interacting protein kinases ...
65316 Ca(2+)/Calmodulin-dependent protein kinase cascade in Caenorhabditis elegans. Implication in transcriptional ...
65317 Ca(2+)/Calmodulin-dependent protein kinase cascade in Caenorhabditis elegans. Implication in transcriptional ...
65318 Ca(2+)/Calmodulin-dependent protein kinase cascade in Caenorhabditis elegans. Implication in transcriptional ...
65319 Ca(2+)/Calmodulin-dependent protein kinase cascade in Caenorhabditis elegans. Implication in transcriptional ...
65320 Phosphorylation of GRK1 and GRK7 by cAMP-dependent protein kinase attenuates their enzymatic activities
65321 Phosphorylation of GRK1 and GRK7 by cAMP-dependent protein kinase attenuates their enzymatic activities
65322 Phosphorylation of GRK1 and GRK7 by cAMP-dependent protein kinase attenuates their enzymatic activities
65323 Phosphorylation of GRK1 and GRK7 by cAMP-dependent protein kinase attenuates their enzymatic activities
65324 GRK1 and GRK7: unique cellular distribution and widely different activities of opsin phosphorylation in the ...
65325 GRK1 and GRK7: unique cellular distribution and widely different activities of opsin phosphorylation in the ...
65326 GRK1 and GRK7: unique cellular distribution and widely different activities of opsin phosphorylation in the ...
65327 GRK1 and GRK7: unique cellular distribution and widely different activities of opsin phosphorylation in the ...
65328 Key residues in Mycobacterium tuberculosis protein kinase G play a role in regulating kinase activity and ...
65329 Key residues in Mycobacterium tuberculosis protein kinase G play a role in regulating kinase activity and ...
65330 Key residues in Mycobacterium tuberculosis protein kinase G play a role in regulating kinase activity and ...
65331 Crystal structure of the Golgi casein kinase
65332 Crystal structure of the Golgi casein kinase
65333 Crystal structure of the Golgi casein kinase
65334 Crystal structure of the Golgi casein kinase
65335 Identification of cardiac-specific myosin light chain kinase
65336 Identification of cardiac-specific myosin light chain kinase
65337 Identification of cardiac-specific myosin light chain kinase
65338 The tricarboxylic acid cycle of Helicobacter pylori
65339 The tricarboxylic acid cycle of Helicobacter pylori
65340 The tricarboxylic acid cycle of Helicobacter pylori
65341 The tricarboxylic acid cycle of Helicobacter pylori
65342 The tricarboxylic acid cycle of Helicobacter pylori
65343 The tricarboxylic acid cycle of Helicobacter pylori
65344 The tricarboxylic acid cycle of Helicobacter pylori
65345 The tricarboxylic acid cycle of Helicobacter pylori
65346 The tricarboxylic acid cycle of Helicobacter pylori
65347 The tricarboxylic acid cycle of Helicobacter pylori
65348 The tricarboxylic acid cycle of Helicobacter pylori
65349 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65350 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65351 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65352 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65353 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65354 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65355 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65356 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65357 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65358 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65359 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65360 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65361 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65362 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65363 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65364 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65365 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65366 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65367 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65368 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65369 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65370 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65371 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65372 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65373 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65374 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65375 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65376 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65377 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65378 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65379 New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
65380 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65381 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65382 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65383 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65384 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65385 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65386 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65387 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65388 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65389 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65390 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65391 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65392 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65393 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65394 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65395 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65396 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65397 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65398 Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate ...
65399 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65400 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65401 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65402 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65403 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65404 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65405 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65406 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65407 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65408 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65409 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65410 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65411 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65412 Characterization of the physicochemical and catalytic properties of human heart NADP-dependent isocitrate ...
65413 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65414 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65415 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65416 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65417 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65418 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65419 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65420 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65421 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65422 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65423 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65424 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65425 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65426 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65427 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65428 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65429 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65430 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65431 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65432 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65433 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65434 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65435 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65436 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65437 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65438 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65439 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65440 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65441 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65442 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65443 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65444 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65445 Molecular mechanisms of isocitrate dehydrogenase 1 (IDH1) mutations identified in tumors: The role of size and ...
65446 Evidence for the physiological role of a rhodanese-like protein for the biosynthesis of the molybdenum ...
65447 Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an ...
65448 Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an ...
65449 Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an ...
65450 Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an ...
65451 Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an ...
65452 Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an ...
65453 Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an ...
65454 Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an ...
65455 Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an ...
65456 An improved manual and semi-automatic assay for NADP-dependent isocitrate dehydrogenase activity, with a ...
65457 An improved manual and semi-automatic assay for NADP-dependent isocitrate dehydrogenase activity, with a ...
65458 An improved manual and semi-automatic assay for NADP-dependent isocitrate dehydrogenase activity, with a ...
65459 An improved manual and semi-automatic assay for NADP-dependent isocitrate dehydrogenase activity, with a ...
65460 An improved manual and semi-automatic assay for NADP-dependent isocitrate dehydrogenase activity, with a ...
65461 An improved manual and semi-automatic assay for NADP-dependent isocitrate dehydrogenase activity, with a ...
65462 An improved manual and semi-automatic assay for NADP-dependent isocitrate dehydrogenase activity, with a ...
65463 An improved manual and semi-automatic assay for NADP-dependent isocitrate dehydrogenase activity, with a ...
65464 An improved manual and semi-automatic assay for NADP-dependent isocitrate dehydrogenase activity, with a ...
65465 An α-1,6-and α-1,3-linked glucan produced by Leuconostoc citreum ABK-1 alternansucrase with nanoparticle and ...
65466 Characterization of two site-specifically mutated human dihydrolipoamide dehydrogenases (His-452----Gln and ...
65467 Characterization of two site-specifically mutated human dihydrolipoamide dehydrogenases (His-452----Gln and ...
65468 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65469 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65470 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65471 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65472 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65473 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65474 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65475 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65476 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65477 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65478 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65479 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65480 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65481 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65482 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65483 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65484 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65485 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65486 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65487 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65488 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65489 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65490 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65491 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65492 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65493 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65494 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65495 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65496 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65497 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65498 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65499 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65500 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65501 Mutant IDH1 enhances the production of 2-hydroxyglutarate due to its kinetic mechanism
65502 Human heart TPN-specific isocitrate dehydrogenase. Purification by a rapid three-step procedure
65503 Human heart TPN-specific isocitrate dehydrogenase. Purification by a rapid three-step procedure
65504 Human heart TPN-specific isocitrate dehydrogenase. Purification by a rapid three-step procedure
65505 Human heart TPN-specific isocitrate dehydrogenase. Purification by a rapid three-step procedure
65506 Human heart TPN-specific isocitrate dehydrogenase. Purification by a rapid three-step procedure
65507 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65508 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65509 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65510 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65511 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65512 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65513 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65514 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65515 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65516 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65517 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65518 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65519 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65520 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65521 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65522 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65523 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65524 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65525 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65526 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65527 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65528 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65529 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65530 Each conserved active site tyr in the three subunits of human isocitrate dehydrogenase has a different ...
65531 A novel nuclear human poly(A) polymerase (PAP), PAP gamma
65532 A novel nuclear human poly(A) polymerase (PAP), PAP gamma
65533 A novel nuclear human poly(A) polymerase (PAP), PAP gamma
65534 A novel nuclear human poly(A) polymerase (PAP), PAP gamma
65535 A novel nuclear human poly(A) polymerase (PAP), PAP gamma
65536 Archaeal RibL: a new FAD synthetase that is air sensitive
65537 Archaeal RibL: a new FAD synthetase that is air sensitive
65538 Archaeal RibL: a new FAD synthetase that is air sensitive
65539 The pentose catabolic pathway of the rice-blast fungus Magnaporthe oryzae involves a novel pentose reductase ...
65540 The pentose catabolic pathway of the rice-blast fungus Magnaporthe oryzae involves a novel pentose reductase ...
65541 Ribosylnicotinamide kinase domain of NadR protein: identification and implications in NAD biosynthesis
65542 Ribosylnicotinamide kinase domain of NadR protein: identification and implications in NAD biosynthesis
65543 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65544 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65545 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65546 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65547 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65548 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65549 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65550 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65551 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65552 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65553 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65554 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65555 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65556 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65557 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65558 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65559 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65560 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65561 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65562 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65563 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65564 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65565 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65566 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65567 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65568 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65569 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65570 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65571 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65572 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65573 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65574 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65575 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65576 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65577 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65578 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65579 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65580 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65581 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65582 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65583 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65584 Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor ...
65585 AtSUC3, a gene encoding a new Arabidopsis sucrose transporter, is expressed in cells adjacent to the vascular ...
65586 AtSUC3, a gene encoding a new Arabidopsis sucrose transporter, is expressed in cells adjacent to the vascular ...
65587 AtSUC3, a gene encoding a new Arabidopsis sucrose transporter, is expressed in cells adjacent to the vascular ...
65588 The Aspergillus niger D-xylulose kinase gene is co-expressed with genes encoding arabinan degrading enzymes, ...
65589 The Aspergillus niger D-xylulose kinase gene is co-expressed with genes encoding arabinan degrading enzymes, ...
65590 The Aspergillus niger D-xylulose kinase gene is co-expressed with genes encoding arabinan degrading enzymes, ...
65591 The Aspergillus niger D-xylulose kinase gene is co-expressed with genes encoding arabinan degrading enzymes, ...
65592 The Aspergillus niger D-xylulose kinase gene is co-expressed with genes encoding arabinan degrading enzymes, ...